close
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep;68(3):318-9.
doi: 10.1111/j.1365-2125.2009.03491.x.

Eculizumab

Eculizumab

Eline A Dubois et al. Br J Clin Pharmacol. 2009 Sep.
No abstract available

PubMed Disclaimer

Figures

None
The membrane attack complex (MAC), the end-product of the terminal complement system, normally does not attack the body's own red blood cells, because CD59 prevents this. However, patients with paroxysmal nocturnal haemoglobinuria (PNH) lack CD59, which allows MAC to attack the red blood cells and cause lysis Eculizumab binds complement C5, thereby inhibiting the entire terminal complement system including the generation of the MAC. In PNH patients this results in a strong decrease in haemolysis, but also reduced clearance of Neisseria

References

    1. Parker CJ, Kar S, Kirkpatrick P. FRESH FROM THE PIPELINE: Eculizumab. Nat Rev Drug Discov. 2007;6:515–16. - PubMed

MeSH terms

LinkOut - more resources